LifeTech Scientific Corporation
Other OTCTotal Valuation
LifeTech Scientific Corporation carries a market capitalization of 1.03B, placing it among publicly traded companies globally. Its enterprise value stands at -153.88M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 1.03B |
| Enterprise Value | -153.88M |
Share Statistics
LifeTech Scientific Corporation currently has 4.00B shares outstanding.
| Shares Outstanding | 4.00B |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Financial Position
LifeTech Scientific Corporation maintains a current ratio of 4.71, meaning it holds 4.7x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 28.41, indicating elevated leverage, while an interest coverage ratio of 4.56 demonstrates adequate ability to service its debt obligations.
| Current Ratio | 4.71 |
| Quick Ratio | 2.91 |
| Debt / Equity | 28.41 |
| Debt / EBITDA | 1.45 |
| Interest Coverage | 4.56 |
Financial Efficiency
| Return on Equity (ROE) | N/A |
| Return on Assets (ROA) | -14.85 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | -181.55 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 1.48 |
Taxes
Over the trailing twelve months, LifeTech Scientific Corporation has paid 12.19M in income taxes, reflecting an effective tax rate of 81.44.
| Income Tax | 12.19M |
| Effective Tax Rate | 81.44 |
Stock Price Statistics
LifeTech Scientific Corporation's stock has gained approximately 0% over the past 52 weeks. The 50-day moving average sits at 0.23, while the 200-day moving average is 0.23.
| Beta (5Y) | N/A |
| 52-Week Price Change | 0% |
| 50-Day Moving Average | 0.23 |
| 200-Day Moving Average | 0.23 |
| Average Volume (20 Days) | N/A |
Income Statement
Over the trailing twelve months, LifeTech Scientific Corporation generated 231.04M in revenue and converted that into -65.67M in net income, yielding earnings per share of -0.02. EBITDA reached 46.21M, while operating income came in at 46.21M.
| Revenue | 231.04M |
| Gross Profit | 188.64M |
| Operating Income | 46.21M |
| Pretax Income | -53.19M |
| Net Income | -65.67M |
| EBITDA | 46.21M |
| EBIT | 46.21M |
| Earnings Per Share (EPS) | -0.02 |
Balance Sheet
LifeTech Scientific Corporation holds 225.47M in cash and equivalents against 67.06M in total debt, resulting in a net debt position of -158.41M. Total book value stands at -82.58M, with working capital of 287.43M providing operational flexibility.
| Cash & Cash Equivalents | 225.47M |
| Total Debt | 67.06M |
| Net Debt | -158.41M |
| Equity (Book Value) | -82.58M |
| Book Value Per Share | -0.02 |
| Working Capital | 287.43M |
Margins
LifeTech Scientific Corporation operates with a gross margin of 81.65, reflecting its pricing power and cost economics. The operating margin of 20.00 and net profit margin of -28.42 provide insight into operational efficiency.
| Gross Margin | 81.65 |
| Operating Margin | 20.00 |
| Pretax Margin | -23.02 |
| Profit Margin | -28.42 |
| EBITDA Margin | 20.00 |
Scores
LifeTech Scientific Corporation posts an Altman Z-Score of 1.26, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 1.26 |